DIVISLABNSEDivi's Laboratories Limited· PharmaceuticalsMinimalNeutral
Announced Thu, 12 Feb · 12:46 IST

Divi's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication

DIVISLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Divi's Laboratories has submitted copies of newspaper clippings to NSE and BSE regarding its unaudited financial results for the quarter and nine months ended December 31, 2025. The notice was published on February 12, 2026 in Financial Express (English, all editions) and Andhra Prabha (Telugu, Hyderabad edition). The results themselves were approved by the Board of Directors on February 11, 2026, based on the Audit Committee's recommendation. The published clipping is only a notice directing investors to the company's website for the full results, so the specific revenue and profit numbers are not disclosed in this filing. This is a routine compliance filing under SEBI's Listing Regulations, not a new earnings announcement.

Likely market impact

No new information for shareholders — this is a regulatory compliance update confirming the Q3 FY26 results have been publicly notified via newspapers. Investors should look at the detailed results already filed on February 11, 2026 for the actual financial performance. The stock is unlikely to react to this particular filing.